Jeffrey Apter

1.3k total citations
18 papers, 806 citations indexed

About

Jeffrey Apter is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Jeffrey Apter has authored 18 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 4 papers in Experimental and Cognitive Psychology. Recurrent topics in Jeffrey Apter's work include Treatment of Major Depression (7 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Electroconvulsive Therapy Studies (4 papers). Jeffrey Apter is often cited by papers focused on Treatment of Major Depression (7 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Electroconvulsive Therapy Studies (4 papers). Jeffrey Apter collaborates with scholars based in United States, Israel and Canada. Jeffrey Apter's co-authors include R. Tepner, Lesley A. Allen, Martin Birkett, Maurizio Fava, Jay D. Amsterdam, Peter D. Londborg, Roy Tamura, David Michelson, Dennis J. Munjack and Lynn Cunningham and has published in prestigious journals such as Annals of the New York Academy of Sciences, The British Journal of Psychiatry and Neuropsychopharmacology.

In The Last Decade

Jeffrey Apter

16 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Apter United States	11	331	245	240	162	155	18	806
Burton J. Goldstein United States	14	242 0.7×	233 1.0×	198 0.8×	176 1.1×	112 0.7×	47	755
Charles S. Wilcox United States	16	320 1.0×	275 1.1×	127 0.5×	272 1.7×	77 0.5×	27	806
Bruce I. Diamond United States	14	170 0.5×	221 0.9×	306 1.3×	89 0.5×	141 0.9×	27	721
Judith Haffmans Netherlands	14	170 0.5×	228 0.9×	224 0.9×	79 0.5×	123 0.8×	33	695
Alexa J.M. Sorant United States	10	367 1.1×	262 1.1×	260 1.1×	94 0.6×	242 1.6×	20	1.0k
Marie‐France Poirier France	17	168 0.5×	412 1.7×	195 0.8×	112 0.7×	116 0.7×	34	964
Alexandra Soliman Canada	8	187 0.6×	184 0.8×	238 1.0×	108 0.7×	91 0.6×	9	713
Goodwin Fk United States	18	244 0.7×	413 1.7×	311 1.3×	134 0.8×	181 1.2×	44	1.1k
Jeffrey Kraft United States	9	301 0.9×	247 1.0×	317 1.3×	91 0.6×	262 1.7×	13	987
Roland Ricken Germany	18	268 0.8×	350 1.4×	143 0.6×	169 1.0×	82 0.5×	35	983

Countries citing papers authored by Jeffrey Apter

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Apter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Apter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Apter more than expected).

Fields of papers citing papers by Jeffrey Apter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Apter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Apter. The network helps show where Jeffrey Apter may publish in the future.

Co-authorship network of co-authors of Jeffrey Apter

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Apter. A scholar is included among the top collaborators of Jeffrey Apter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Apter. Jeffrey Apter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Apter, Jeffrey, et al.. (2015). Update on Disease-Modifying/Preventive Therapies in Alzheimer’s Disease. Current Geriatrics Reports. 4(4). 312–317. 11 indexed citations

Woolfolk, Robert L., Lesley A. Allen, & Jeffrey Apter. (2011). Affective-Cognitive Behavioral Therapy for Fibromyalgia: A Randomized Controlled Trial. Pain Research and Treatment. 2012. 1–6. 14 indexed citations

Apter, Jeffrey. (2010). Abstract #1: EVP-6124 Elicits Pro-Cognitive Effects in Alzheimer's Patients. Neurotherapeutics. 7(3). 328–328. 1 indexed citations

Cooper‐Kazaz, Rena, Jeffrey Apter, Daniel Grupper, et al.. (2007). Combined Treatment With Sertraline and Liothyronine in Major Depression. Archives of General Psychiatry. 64(6). 679–679. 71 indexed citations

Kramer, Mark S., Andrew Winokur, Jeffrey E. Kelsey, et al.. (2003). Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression. Neuropsychopharmacology. 29(2). 385–392. 219 indexed citations

Michelson, David, Maurizio Fava, Jay D. Amsterdam, et al.. (2000). Interruption of selective serotonin reuptake inhibitor treatment. The British Journal of Psychiatry. 176(4). 363–368. 131 indexed citations

Michelson, David, Jay D. Amsterdam, Jeffrey Apter, et al.. (2000). Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment. Psychoneuroendocrinology. 25(2). 169–177. 29 indexed citations

Apter, Jeffrey & Lesley A. Allen. (1999). Buspirone. Journal of Clinical Psychopharmacology. 19(1). 86–93. 58 indexed citations

Kronig, Michael H., Jeffrey Apter, Gregory M. Asnis, et al.. (1999). Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology. 19(2). 172–176. 56 indexed citations

10.

Birkett, Martin, et al.. (1997). Fluoxetine Treatment of Patients With Major Depressive Disorder Who Failed Initial Treatment With Sertraline. The Journal of Clinical Psychiatry. 58(1). 16–21. 147 indexed citations

11.

Apter, Jeffrey, James A. Halikas, Richard L. Borison, et al.. (1996). The Oral Dose-Effect Relationship for Fluvoxamine: a Fixed-Dose Comparison Against Placebo in Depressed Outpatients. Annals of Clinical Psychiatry. 8(3). 139–151. 41 indexed citations

12.

Wolkow, Robert, Jeffrey Apter, Anita H. Clayton, et al.. (1996). Double-blind flexible dose study of sertraline and placebo in patients with panic disorder. European Neuropsychopharmacology. 6. 113–113. 3 indexed citations

13.

Apter, Jeffrey & William M. Greenberg. (1994). New drug development in psychiatry. 2(8). 87–100. 1 indexed citations

14.

Apter, Jeffrey, Stuart Kushner, & Robert L. Woolfolk. (1994). Bupropion/Nortriptyline Combination for Refractory Depression. Annals of Clinical Psychiatry. 6(4). 255–258. 5 indexed citations

15.

Apter, Jeffrey. (1994). New Drug Development --- Alzheimer' Disease. Neuropsychopharmacology. 11(4). 264–264. 1 indexed citations

16.

Apter, Jeffrey & Robert L. Woolfolk. (1990). Lithium Augmentation of Bupropion in Refractory Depression. Annals of Clinical Psychiatry. 2(1). 7–10. 4 indexed citations

17.

Varga, E, A. Arthur Sugerman, & Jeffrey Apter. (1982). THE EFFECT OF CODEINE ON INVOLUTIONAL AND SENILE DEPRESSION. Annals of the New York Academy of Sciences. 398(1). 103–105. 10 indexed citations

18.

Apter, Jeffrey, et al.. (1982). Side Effects and toxicity of lithium.. PubMed. 15(6). 1101–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact